Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001520138-21-000400
Filing Date
2021-08-06
Accepted
2021-08-06 17:21:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 bivi-20210806_424b5.htm 424B5 406892
2 GRAPHIC image_001.jpg GRAPHIC 1901
3 GRAPHIC image_002.gif GRAPHIC 15052
4 GRAPHIC image_003.jpg GRAPHIC 1901
5 GRAPHIC image_004.jpg GRAPHIC 15167
  Complete submission text file 0001520138-21-000400.txt   455381
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-252386 | Film No.: 211153905
SIC: 2834 Pharmaceutical Preparations